Gemtuzumab Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Gemtuzumab Side Effects
Did You Have Gemtuzumab Side Effect? |
Gemtuzumab Side Effects Poll Results |
|
Vote Below:
|
|
Gemtuzumab Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Gemtuzumab:
What is Your Question? Ask Community:
Daily Health Videos
Gemtuzumab Side Effects reported on Patientsville.com
None reported at this time.Gemtuzumab Side Effects reported to FDA
Showing 1-50 of 371 Next >
Gemtuzumab Side Effects Report #5210315-5Consumer or non-health professional from ITALY reported Gemtuzumab side effect on Jan 05, 2007. Male patient, 83 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, colitis ischaemic, disease progression, infection
, intestinal haemorrhage, respiratory distress. Gemtuzumab dosage: 5 MG; SEE IMAGE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GLAZIDIM, TRIDECANAMINE, LEVOFLOXACIN, VORICONAZOLE, MEROPENEM, CYTARABINE. Patient died.
Gemtuzumab Side Effects Report #5217741-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 15, 2007. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome. Gemtuzumab dosage: unknown. Patient recovered.
Gemtuzumab Side Effects Report #5225705-4
Consumer or non-health professional from BELGIUM reported Gemtuzumab side effect on Jan 22, 2007. Female patient, 86 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebrovascular accident, sepsis
. Gemtuzumab dosage: 2.6 MG GIVEN AT LAST ADMINISTRATION; CUMULATIVE DOSE 14.3 MG. Patient died.Gemtuzumab Side Effects Report #5226097-7
Gemtuzumab side effect was reported by a Physician from BELGIUM on Jan 22, 2007. Female patient, weighting 98.11 lb, was diagnosed with acute myeloid leukaemia, atrial fibrillation
and was treated with Gemtuzumab. Gemtuzumab dosage: 2.6 MG GIVEN AT LAST ADMINISTRATION; CUMULATIVE DOSE 14.3 MG AFTER ONE CYCLE. During the same period patient was treated with ULTRA K, SERPEN, CORDARONE, MEDROL. Patient died on 01/11/2007.Gemtuzumab Side Effects Report #5227272-8
Physician from GERMANY reported Gemtuzumab side effect on Jan 30, 2007. Male patient, weighting 165.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction. Gemtuzumab dosage: TOTAL DOSE RECEIVED DURING FIRST CYCLE 11.0 MG. During the same period patient was treated with ETOPOSIDE, CYTARABINE, MITOXANTRONE. Patient died on 06/27/2005.
Gemtuzumab Side Effects Report #5227273-X
Gemtuzumab side effect was reported by a Physician from FRANCE on Jan 29, 2007. Female patient was diagnosed with acute myeloid leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: refractoriness to platelet transfusion, venoocclusive liver disease. Gemtuzumab dosage: 10 MG. During the same period patient was treated with NOVANTRONE, ZOFRAN, ACYCLOVIR, TIENAM, TRIFLUCAN, INIPOMP, CHIBRO, ARACYTINE. Patient recovered.
Gemtuzumab Side Effects Report #5243941-8
Pharmacist from UNITED STATES reported Gemtuzumab side effect on Feb 20, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood pressure decreased, chills, pain
. Gemtuzumab dosage: unknown. During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5246876-X
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on Feb 14, 2007. Female patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchitis
, diarrhoea, fatigue, febrile neutropenia, nausea . Gemtuzumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, MAALOX FAST BLOCKER. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5246877-1
Physician from FRANCE reported Gemtuzumab side effect on Feb 21, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: infusion site haemorrhage. Gemtuzumab dosage: SINGLE DOSE: 5.5 MG; CUMULATIVE DOSE: 28.5 MG. During the same period patient was treated with ETOPOSIDE, IDARUBICIN, ARACYTIN. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5258283-4
Gemtuzumab side effect was reported by a Physician from BELGIUM on Mar 02, 2007. Female patient, 44 years of age, weighting 102.5 lb, was diagnosed with antifungal prophylaxis and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemtuzumab dosage: unknown. During the same period patient was treated with TPN ELECTROLYTES IN PLASTIC CONTAINER, DIFLUCAN, LARGACTIL, IDARUBICIN, CYTARABINE. Patient died on 04/16/2006.
Gemtuzumab Side Effects Report #5259180-0
Physician from FRANCE reported Gemtuzumab side effect on Mar 05, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: infusion site haemorrhage, thrombocytopenia. Gemtuzumab dosage: SINGLE DOSE: 5.5 MG; CUMULATIVE DOSE: 28.5 MG. During the same period patient was treated with ZOFRAN, IDARUBICIN, ARACYTIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5259681-5
Gemtuzumab side effect was reported by a Physician from FRANCE on Mar 05, 2007. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, tuberculosis
. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5270170-4
Physician from ITALY reported Gemtuzumab side effect on Mar 15, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with AMIKACIN, TEICOPLANIN, MEROPENEM. Patient died on 01/25/2006.
Gemtuzumab Side Effects Report #5270231-X
Gemtuzumab side effect was reported by a Physician from GERMANY on Mar 15, 2007. Male patient, weighting 183.0 lb, was diagnosed with hypertension and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction, sepsis
. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with ETOPOSIDE, RAMIPRIL, NOVANTRONE. Patient was hospitalized. Patient died on 12/12/2005.Gemtuzumab Side Effects Report #5270232-1
Physician from PORTUGAL reported Gemtuzumab side effect on Mar 15, 2007. Female patient, weighting 178.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bradycardia, hypersensitivity, hypotension, hypoxia, somnolence. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, FLUCONAZOLE, ACYCLOVIR. Patient recovered.
Gemtuzumab Side Effects Report #5270233-3
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on Mar 15, 2007. Female patient, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: infection
, multi-organ failure, respiratory failure. Gemtuzumab dosage: 5MG/M2 FOR ONE DAY ON DAY 7. During the same period patient was treated with COMOX, COLISTIN, IDARUBICIN, CYTARABINE. Patient died on 01/02/2006.Gemtuzumab Side Effects Report #5270235-7
Physician from BELGIUM reported Gemtuzumab side effect on Mar 15, 2007. Male patient, weighting 147.7 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemtuzumab dosage: unknown. During the same period patient was treated with IDARUBICIN. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5270239-4
Gemtuzumab side effect was reported by a Physician from BELGIUM on Mar 15, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia, pyrexia, weight increased and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: emphysema. Gemtuzumab dosage: A SINGLE 11 MG DOSE. During the same period patient was treated with FLUCONAZOLE, ZOVIRAX, CONTRAMAL, EUSAPRIMTE, PERFALGAN, NYSTATIN, TARGOCID, LASIX. Patient died on 09/11/2005.
Gemtuzumab Side Effects Report #5276095-2
Physician from NETHERLANDS reported Gemtuzumab side effect on Mar 15, 2007. Female patient, weighting 149.9 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, candidiasis, fluid retention, hepatic function abnormal, lung infiltration. Gemtuzumab dosage: 5.2 MG. During the same period patient was treated with COLISTIN, IDARUBICIN, CYTARABINE, ETOPOSIDE. Patient died on 01/16/2004.Gemtuzumab Side Effects Report #5276104-0
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 15, 2007. Female patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: lung infection, respiratory failure. Gemtuzumab dosage: 10 MG. During the same period patient was treated with LEVOFLOXACIN, CYTARABINE, MITOXANTRONE, ETOPOSIDE. Patient died on 02/02/2005.
Gemtuzumab Side Effects Report #5277131-X
Physician from BELGIUM reported Gemtuzumab side effect on Mar 15, 2007. Male patient, weighting 186.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, condition aggravated, disseminated intravascular coagulation, hepatocellular damage, multi-organ failure. Gemtuzumab dosage: unknown. During the same period patient was treated with MERONEM, TARGOCID. Patient died on 03/23/2004.
Gemtuzumab Side Effects Report #5288624-3
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 30, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, infection
, respiratory distress. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.Gemtuzumab Side Effects Report #5291103-0
Physician from BELGIUM reported Gemtuzumab side effect on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.
Gemtuzumab Side Effects Report #5292219-5
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.
Gemtuzumab Side Effects Report #5293573-0
Physician from FRANCE reported Gemtuzumab side effect on Apr 06, 2007. Male patient, 49 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: disease progression, multi-organ failure, venoocclusive liver disease. Gemtuzumab dosage: unknown. During the same period patient was treated with ACYCLOVIR, VANCOMYCIN, FLUDARABINE PHOSPHATE, IDARUBICIN, INIPOMP, CONTRAMAL, CIPROFLOXACIN, ZOPHREN. Patient died on 03/03/2007.
Gemtuzumab Side Effects Report #5294845-6
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 10, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.
Gemtuzumab Side Effects Report #5297246-X
Physician from BELGIUM reported Gemtuzumab side effect on Apr 10, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspergillosis, neutropenia, pneumonia
, sepsis , thrombocytopenia. Gemtuzumab dosage: DAILY DOSE 5 MG;CUMULATIVE DOSE 15 MG. Patient was hospitalized. Patient died on 11/08/2006.Gemtuzumab Side Effects Report #5297997-7
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 11, 2007. Male patient, 62 years of age, weighting 154.3 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, encephalopathy, hepatotoxicity, pyrexia, rectal haemorrhage. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5298828-1
Physician from ITALY reported Gemtuzumab side effect on Apr 05, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.
Gemtuzumab Side Effects Report #5300516-X
Gemtuzumab side effect was reported by a Health Professional from UNITED STATES on Apr 13, 2007. Male patient, weighting 181.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hepatotoxicity. Gemtuzumab dosage: 9 MG/M2/DAY -18.27 X1 IV DRIP. Patient recovered.
Gemtuzumab Side Effects Report #5300878-3
Physician from FRANCE reported Gemtuzumab side effect on Apr 17, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: infusion site haemorrhage, thrombocytopenia. Gemtuzumab dosage: SINGLE DOSE: 5.5 MG; CUMULATIVE DOSE: 28.5 MG. During the same period patient was treated with ZOPHREN, IDARUBICIN, ARACYTIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5303395-X
Gemtuzumab side effect was reported by a Physician from GERMANY on Apr 16, 2007. Male patient, weighting 146.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, subdural haematoma. Gemtuzumab dosage: 10.98 MG FOR A TOTAL DOSE OF 21.960. Patient was hospitalized. Patient died on 09/04/2006.
Gemtuzumab Side Effects Report #5305824-4
Physician from GERMANY reported Gemtuzumab side effect on Apr 17, 2007. Male patient, weighting 165.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction. Gemtuzumab dosage: TOTAL DOSE RECEIVED DURING FIRST CYCLE 11.0 MG. During the same period patient was treated with ETOPOSIDE, CYTARABINE, MITOXANTRONE. Patient died on 06/27/2005.
Gemtuzumab Side Effects Report #5338594-4
Gemtuzumab side effect was reported by a Physician from ITALY on May 25, 2007. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, sepsis
. Gemtuzumab dosage: CUMULATIVE DOSE GIVEN 19.50 MG (3.00 MG GIVEN AT LAST DOSE). During the same period patient was treated with IDARUBICIN. Patient was hospitalized. Patient died on 05/16/2007.Gemtuzumab Side Effects Report #5353990-7
Physician from ITALY reported Gemtuzumab side effect on June 07, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac arrest , enteritis, febrile neutropenia. Gemtuzumab dosage: ACTUAL DOSE GIVEN .051 MG (CUMULATIVE DOSE GIVEN 15.500 MG). During the same period patient was treated with TAZOCIN, AMIODARONE, VFEND, IDARUBICIN. Patient was hospitalized. Patient died on 05/30/2007.Gemtuzumab Side Effects Report #5354356-6
Gemtuzumab side effect was reported by a Physician from ITALY on June 01, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia, vomiting and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, septic shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.
Gemtuzumab Side Effects Report #5363276-2
Physician from ITALY reported Gemtuzumab side effect on June 11, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, intestinal haemorrhage, pneumonia
. Gemtuzumab dosage: ACTUAL DOSE 5 MG; CUMMULATIVE DOSE 15 MG. During the same period patient was treated with MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.Gemtuzumab Side Effects Report #5366964-7
Gemtuzumab side effect was reported by a Physician from ITALY on June 19, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac arrest , enteritis, febrile neutropenia. Gemtuzumab dosage: ACTUAL DOSE GIVEN .051 MG (CUMULATIVE DOSE GIVEN 15.500 MG). During the same period patient was treated with IDARUBICIN, TAZOCIN, CYTARABINE. Patient was hospitalized. Patient died on 05/30/2007.Gemtuzumab Side Effects Report #5372242-2
Physician from ITALY reported Gemtuzumab side effect on June 21, 2007. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bone marrow failure, cyanosis, multi-organ failure, sepsis
, shock. Gemtuzumab dosage: CUMULATIVE DOSE GIVEN 19.50 MG (3.00 MG GIVEN AT LAST DOSE). During the same period patient was treated with IDARUBICIN. Patient was hospitalized. Patient died on 05/16/2007.Gemtuzumab Side Effects Report #5374754-4
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on June 28, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: lung infection, respiratory failure. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5055220-2
Consumer or non-health professional from GERMANY reported Gemtuzumab side effect on July 05, 2006. Female patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, arrhythmia
, blood lactate dehydrogenase increased, electrocardiogram st segment depression, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, RAMIPRIL. Patient was hospitalized. Patient died.Gemtuzumab Side Effects Report #5055222-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on July 05, 2006. Male patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, arrhythmia
, blood lactate dehydrogenase increased, electrocardiogram st segment depression, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, RAMIPRIL. Patient was hospitalized. Patient died.Gemtuzumab Side Effects Report #5055223-8
Consumer or non-health professional from ITALY reported Gemtuzumab side effect on July 03, 2006. Female patient, 63 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood ph increased, haemoglobin decreased, lung infection, platelet count decreased, red blood cell count decreased, respiratory failure, staphylococcal infection
. Gemtuzumab dosage: 10 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, LEVOFLOXACIN. Patient died.Gemtuzumab Side Effects Report #5056321-5
Gemtuzumab side effect was reported by a Health Professional from GERMANY on July 05, 2006. Male patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE. Patient was hospitalized. Patient died.
Gemtuzumab Side Effects Report #5060142-7
Consumer or non-health professional from UNITED KINGDOM reported Gemtuzumab side effect on July 10, 2006. Male patient, 41 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: adverse event. Gemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, CYTARABINE, NEUPOGEN. Patient recovered.
Gemtuzumab Side Effects Report #5060302-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2006. Female patient, 43 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: biliary sepsis. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5061707-9
Consumer or non-health professional from POLAND reported Gemtuzumab side effect on July 11, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase decreased, atelectasis, condition aggravated, enterococcal infection, fibrin d dimer increased, gamma-glutamyltransferase increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia. Gemtuzumab dosage: 3 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL, AMIKIN. Patient died.
Gemtuzumab Side Effects Report #5071800-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2006. Male patient, 41 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: adverse event. Gemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE, CYTARABINE, GRANULOCYTE COLONY STIMULATING FACTOR. Patient recovered.
Gemtuzumab Side Effects Report #5071815-4
Consumer or non-health professional from UNITED KINGDOM reported Gemtuzumab side effect on July 24, 2006. Female patient, 43 years of age, was diagnosed with acute leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: biliary sepsis. Gemtuzumab dosage: unknown. During the same period patient was treated with DOMPERIDONE, OMEPRAZOLE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5078153-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from BELGIUM on Aug 02, 2006. Female patient, 44 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma. Gemtuzumab dosage: 7 MG 1X PER 1 DAY. During the same period patient was treated with CYTARABINE, IDARUBICIN, DIFLUCAN, CHLORPROMAZINE, AMINOMIX. Patient died.
Showing 1-50 of 371 Next >